Skip to content
Home » Researchers develop fully functional skin tissue using human stem cells

Researchers develop fully functional skin tissue using human stem cells

Queensland researchers have become the first in Australia to use human to generate fully functioning skin tissue in a laboratory, a significant step toward better treatments for severe burns and .

The skin tissue, produced by The University of Queensland's Frazer Institute and Metro North Health's Herston Biofabrication Institute, can develop hair follicles and neurons as well as sebaceous and . A research paper on the process has been published in the journal Small.

Project leader Dr. Abbas Shafiee said the generated skin mimics that of the more closely than existing skin substitutes.

“We used a variety of stem cell lines and tested different procedures to grow , which are 3D skin tissues created by researchers in a laboratory,” Dr. Shafiee said.

“Human stem were first converted into cells which can grow to be any tissue in the .

“These ‘induced pluripotent' stem cells were then formed into spheres, which underwent four months of differentiation to produce the skin organoids.

“This has the potential to improve the quality of life of patients with severe burn injuries, and those who live with the pain caused by scarring from previous skin grafts.”

Professor Kiarash Khosrotehrani said the technology will allow researchers to design new strategies in areas such as wound care, and hair transplantation.

A skin organoid, stained with key human skin markers, at 90 days differentiation. The blue color marks the cell nucleus, green is Keratin 10 and red is Keratin 19. Credit: Small (2023). DOI: 10.1002/smll.202304879

“Researchers and clinicians being able to produce more realistic skin could be transformative for people who have suffered severe wounds or burns,” Professor Khosrotehrani said.

“The wound site will be less irritated and look more like the rest of the patient's skin.”

The researchers hope to progress toward translational studies of the technology, with prospects leading to clinical .

The research was a collaboration between the Experimental Dermatology Group at UQ's Frazer Institute and Metro North Health's Herston Biofabrication Institute.